Does METOPROLOL Cause Hypertransaminasaemia? 19 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Hypertransaminasaemia have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.1% of all adverse event reports for METOPROLOL.
19
Reports of Hypertransaminasaemia with METOPROLOL
0.1%
of all METOPROLOL reports
1
Deaths
17
Hospitalizations
How Dangerous Is Hypertransaminasaemia From METOPROLOL?
Of the 19 reports, 1 (5.3%) resulted in death, 17 (89.5%) required hospitalization, and 12 (63.2%) were considered life-threatening.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)
Which METOPROLOL Alternatives Have Lower Hypertransaminasaemia Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE